The COVID-19 and Cancer Consortium: A Collaborative Effort to Understand the Effects of COVID-19 on Patients with Cancer

Cancer Cell. 2020 Jun 8;37(6):738-741. doi: 10.1016/j.ccell.2020.04.018. Epub 2020 Apr 29.

Abstract

National and international consortia will play a key role in understanding the effects of the coronavirus disease 2019 (COVID-19) pandemic on cancer patients. The COVID-19 and Cancer Consortium (CCC19) aims to collect and analyze observational data at scale to inform clinical practice in real-time.

MeSH terms

  • Betacoronavirus / isolation & purification*
  • Betacoronavirus / pathogenicity
  • COVID-19
  • Canada
  • Clinical Decision-Making
  • Coronavirus Infections / complications
  • Coronavirus Infections / epidemiology
  • Coronavirus Infections / therapy*
  • Coronavirus Infections / virology
  • Crowdsourcing
  • Drug Repositioning
  • Humans
  • International Cooperation
  • Intersectoral Collaboration
  • Medical Oncology / organization & administration*
  • Neoplasms / complications
  • Neoplasms / therapy*
  • Pandemics
  • Pneumonia, Viral / complications
  • Pneumonia, Viral / epidemiology
  • Pneumonia, Viral / therapy*
  • Pneumonia, Viral / virology
  • Registries*
  • SARS-CoV-2
  • Spain
  • United States